<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
    <journal-title-group>
      <journal-title>Nature Communications</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2041-1723</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9424320</article-id>
    <article-id pub-id-type="publisher-id">32661</article-id>
    <article-id pub-id-type="doi">10.1038/s41467-022-32661-x</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>The automated Galaxy-SynBioCAD pipeline for synthetic biology design and engineering</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Hérisson</surname>
          <given-names>Joan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2649-2950</contrib-id>
        <name>
          <surname>Duigou</surname>
          <given-names>Thomas</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>du Lac</surname>
          <given-names>Melchior</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bazi-Kabbaj</surname>
          <given-names>Kenza</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sabeti Azad</surname>
          <given-names>Mahnaz</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Buldum</surname>
          <given-names>Gizem</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Telle</surname>
          <given-names>Olivier</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>El Moubayed</surname>
          <given-names>Yorgo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0993-5625</contrib-id>
        <name>
          <surname>Carbonell</surname>
          <given-names>Pablo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Swainston</surname>
          <given-names>Neil</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zulkower</surname>
          <given-names>Valentin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8850-3272</contrib-id>
        <name>
          <surname>Kushwaha</surname>
          <given-names>Manish</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4800-023X</contrib-id>
        <name>
          <surname>Baldwin</surname>
          <given-names>Geoff S.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Faulon</surname>
          <given-names>Jean-Loup</given-names>
        </name>
        <address>
          <email>Jean-Loup.Faulon@inrae.fr</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.460789.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 6535</institution-id><institution>Genomics Metabolics, Genoscope, François Jacob Institute, CEA, CNRS, Univ Evry, </institution><institution>Université Paris-Saclay, </institution></institution-wrap>91057 Evry, France </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.462293.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0522 0627</institution-id><institution>Université Paris-Saclay, INRAE, AgroParisTech, </institution><institution>Micalis Institute, </institution></institution-wrap>78352 Jouy-en-Josas, France </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.432482.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0455 3323</institution-id><institution>Amyris Inc, </institution></institution-wrap>Emeryville, CA 94608-2405 US </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution>Imperial College Centre for Synthetic Biology, Department of Life Sciences, Imperial College, </institution></institution-wrap>London, SW7 2AZ UK </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution>Manchester Institute of Biotechnology, SYNBIOCHEM center, School of Chemistry, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, M1 7DN UK </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.157927.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1770 5832</institution-id><institution>Institute of Industrial Control Systems and Computing (ai2), </institution><institution>Universitat Politècnica de València, </institution></institution-wrap>46022 Valencia, Spain </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.10025.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8470</institution-id><institution>Institute of Systems, </institution><institution>Molecular and Integrative Biology University of Liverpool, </institution></institution-wrap>Liverpool, L69 7ZB UK </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>Edinburgh Genome Foundry, SynthSys, School of Biological Sciences, </institution><institution>University of Edinburgh, </institution></institution-wrap>EH93BF Edinburgh, UK </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>29</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>13</volume>
    <elocation-id>5082</elocation-id>
    <history>
      <date date-type="received">
        <day>4</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>11</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Here we introduce the Galaxy-SynBioCAD portal, a toolshed for synthetic biology, metabolic engineering, and industrial biotechnology. The tools and workflows currently shared on the portal enables one to build libraries of strains producing desired chemical targets covering an end-to-end metabolic pathway design and engineering process from the selection of strains and targets, the design of DNA parts to be assembled, to the generation of scripts driving liquid handlers for plasmid assembly and strain transformations. Standard formats like SBML and SBOL are used throughout to enforce the compatibility of the tools. In a study carried out at four different sites, we illustrate the link between pathway design and engineering with the building of a library of <italic>E. coli</italic> lycopene-producing strains. We also benchmark our workflows on literature and expert validated pathways. Overall, we find an 83% success rate in retrieving the validated pathways among the top 10 pathways generated by the workflows.</p>
    </abstract>
    <abstract id="Abs2" abstract-type="web-summary">
      <p id="Par2">Automated design and build processes can rapidly accelerate work in synthetic biology and metabolic engineering. Here the authors present Galaxy-SynBioCAD, a toolshed for synthetic biology, metabolic engineering, and industrial biotechnology that they use to build and execute Galaxy scientific workflows from pathway design to strain engineering through the automated generation of scripts driving robotic workstations.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Synthetic biology</kwd>
      <kwd>Biochemical reaction networks</kwd>
      <kwd>Computational platforms and environments</kwd>
      <kwd>Metabolic engineering</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100010661</institution-id>
            <institution>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>730976</award-id>
        <award-id>820699</award-id>
        <principal-award-recipient>
          <name>
            <surname>Faulon</surname>
            <given-names>Jean-Loup</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000268</institution-id>
            <institution>RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>BB/M017702/1</award-id>
        <award-id>BB/S004955/1</award-id>
        <award-id>BB/M025659/1</award-id>
        <award-id>BB/M0101804/1</award-id>
        <award-id>EP/R034915/1</award-id>
        <principal-award-recipient>
          <name>
            <surname>Faulon</surname>
            <given-names>Jean-Loup</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>ANR EQUIPEX+ program grant ALADIN ANR grant 21‐CE48‐003</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1" sec-type="introduction">
    <title>Introduction</title>
    <p id="Par3">Computation has become an essential tool in life science research. Synthetic biology, metabolic engineering and industrial biotechnology make no exception to that trend. As part of this endeavor, significant attention is being paid to the development of workflows adhering to design principles from engineering such as standardization and abstraction of modular parts, as well as the decoupling of design from fabrication.</p>
    <p id="Par4">Following the electronic design automation (EDA) concept, there are many design automation tools for genetic circuits, these are extensively reviewed in Appleton et al.<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. As an example, Cello<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> applies the EDA approach to genetic circuits. Cello comprises several steps, which are connected and therefore need to use standardized input/output formats. Among those formats are Verilog to represent a logic function and Eugene<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> to encode a set of parts and constraints between the parts. Although Cello achieved the compilation and standardization of several pieces of software for genetic design, in general, this is not true for most freely available synthetic biology and metabolic engineering design tools, where the fragmentation remains a significant barrier to adoption. Nonetheless, two main standards have emerged in the past two decades. The first, SBML<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> is a biological modeling standard that has been developed by the systems biology community to encode strains and pathways. The second, SBOL<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, is a data exchange standard specific to synthetic biology. SBOL has been developed to document genetic components (DNA, RNA, protein, etc.) and their interactions for the purpose of biodesign engineering. SBOL can now encode complex genetic circuits, metabolic pathways, vectors, and plasmids. Complying with SBML and SBOL standards a suite of in silico genetic circuit design tools was recently proposed<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p>
    <p id="Par5">As for genetic circuits, there are plenty of software tools to assist the biosynthetic pathway design process<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Briefly, from a given target compound and a given chassis strain, the first step consists of finding metabolic reactions that link the target compound to the native metabolites of the host strain. This step is carried out by retrosynthesis software tools<sup><xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup> and, should one wish to search for novel pathways or find pathways that produce unnatural target compounds, requires the use of reaction rules<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. The result of retrosynthesis is a metabolic map and there is a need in a second step to enumerate the pathways linking the chassis metabolites to the target. There are many solutions for pathway enumeration and search<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, which are sometimes integrated into the retrosynthesis software itself. The third step is to find the most promising enzyme sequences catalyzing the metabolic reactions. This can be achieved either through similarity search to enzyme annotated metabolic reactions<sup><xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref></sup>, or machine learning trained on metabolic databases<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. Once the pathways have been annotated with enzyme sequences, they can be ranked in a fourth step. The ranking criteria are diverse, they can be among others based on thermodynamics<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, predicted yield of the target<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, target rate of production through flux balance analysis<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>, chassis cytotoxicity of the target and intermediates<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, along with simpler criteria like pathway length.</p>
    <p id="Par6">In addition to the enzyme identities, there are multiple layout solutions and settings to engineer the top-ranked pathways. Indeed, the individual genes coding for the enzyme can be placed under different promoters, in a different order within an operon, with different RBS strength (if the chassis is a bacteria), and on different plasmids with different origins of replication if the engineering is performed on a plasmid. The fifth step deals with this issue by making use of tools such as the RBS calculator<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> to compute RBS sequences for different strengths, and design of experiments (DoE)<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> to sample the space of possible constructs, which can be very large. The result of that step is a library of layouts representing either the same or different pathways. At this stage, one can either synthesize the whole layout DNA or, as it is most commonly done, synthesize individual DNA parts and use combinatorial DNA assembly methods to include variations of the control elements, such as promoters and RBS sequences. Several computational tools can be used to perform this <italic>sixth</italic> and last step of assembly design before constructing the pathways, these tools compute parts to be synthesized depending on the chosen assembly protocol. Computation tools to help the build tasks are sparser than for design. One can cite here Aquarium<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, which provides instructions to a person or a robot to perform the assembly tasks along with Antha<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, BioBlocks<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, and DNA-BOT<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Engineered pathways are generally evaluated using HPLC or mass spectrometry analyses. Here too, computational tools can help in particular the workflows produced by OpenMS<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> or Worlflow4Metabolomics<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
    <p id="Par7">Considering the above, we are clearly at a stage where the pathway engineering process is not that far from being fully driven by computer software products. However, there are several hurdles that prevent this from happening even for tools covering pathway design only. First, the tools are not easily findable, they are stored in different places and the keywords to search online are not obvious. Secondly, some of the tools are difficult to access, some requiring registration, purchase, or access fees. Thirdly, almost none of the tools are interoperable and cannot be chained one after another to ensure that computational experiments are communicated well, and hence reproducible. Lastly, and perhaps most problematic for wider acceptance, the tools can be difficult to comprehend, requiring a level of expertize that limits their use by a large community.</p>
    <p id="Par8">Scientific workflows help to address these issues by providing an open, web-based platform for performing findable and accessible data analyses linked to experimental protocols for all scientists irrespectively of their informatics expertize, along with interoperable and reproducible computations regardless of the particular platform that is being used<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Indeed, without programming skills, scientists that need to use computational approaches are impeded by difficulties ranging from tool installation to determining which parameter values to use, to efficiently combining and interfacing multiple tools together in an analysis chain. Scientific workflows provide solutions where data is combined and processed into a configurable, structured set of steps. Existing systems often provide graphical user interfaces to combine different technologies along with efficient methods for using them, and thus increase the efficiency of the scientists using them. In addition, workflow systems generally provide a platform for developers seeking a wider audience and broad integration of their tools, and can thus drive forward further developments in a specific field of research. Among existing workflow platforms, Galaxy is a system originally developed for genome analysis<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> which now includes more than 8500 tools that can be found in the public ToolShed<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>.</p>
    <p id="Par9">Here, we introduce the Galaxy-SynBioCAD portal<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, a Galaxy set of tools for synthetic biology, metabolic engineering and industrial biotechnology. It allows one to easily create workflows from the incorporated toolset or use already developed shared workflows. The portal is a growing community effort where developers can add new tools and users can evaluate the tools performing design for their specific projects. The tools and workflows currently shared on the Galaxy-SynBioCAD portal cover an end-to-end metabolic pathway design and engineering process from the selection of strain and target to automated DNA parts assembly and strain transformation.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <sec id="Sec3">
      <title>Tools selection criteria</title>
      <p id="Par10">To develop an integrated ecosystem, we selected software applications from among the computational tools mentioned above. Several criteria were used for this selection: the tools needed to (i) be relevant for pathway design and engineering, (ii) be published, (iii) be open-source (MIT, GNU GPL, or related licenses), (iv) be well documented and deposited in GitHub, (v) make use of standard input/output, and (vi) exist as a standalone command-line tool. Within a workflow, each tool connected to one or more tools must share common file format for data exchange, i.e., each output file of a tool has to be compatible with the input file format of downstream tools in the workflow. The file format relies on the nature of the data (e.g., metabolic model, metabolic pathway, and construct design) and the implementation choice made for each tool. Among the standard formats used, some are rather generic (CSV, TSV, JSON) while others are more specific to a scientific field (e.g., SBOL, SBML).</p>
    </sec>
    <sec id="Sec4">
      <title>Pathway design and engineering tools and workflows</title>
      <p id="Par11">The selected tools are further described in the ‘Supplementary_Text’ file (cf. Galaxy-SynBioCAD Tools). These tools can be divided in three categories: (i) those aimed at finding pathways to synthesize heterologous compounds in chassis organisms (RetroRules, RetroPath2.0, RP2Paths, and rpCompletion), (ii) those aimed at evaluating and ranking pathways (rpThermo, rpFBA, rpReport, rpViz, and rpScore) and (iii) those related to genetic design and engineering (Selenzyme, SbmlToSbol, PartsGenie, OptDOE, DNA Weaver, LCR Genie, rpBASICDesign, and DNA-Bot). Following FAIR principles<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, all selected tools are open-source with code available on GitHub and installable through the Conda package manager<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> (cf. Tools design and integration process in the ‘Supplementary_Text’ file). Therefore, any user can install the tools needed on their own computer and run these as standalone programs or chain them together to process more complex calculations.</p>
      <p id="Par12">To go further in chaining tools, three types of Galaxy workflows are available on the Galaxy-SynBioCAD portal.<list list-type="order"><list-item><p id="Par13">A Retrosynthesis workflow to enumerate the pathways enabling the synthesis of a given target chemical in a host chassis organism (cf. Retrosynthesis from target to chassis in Methods section and Retrosynthesis workflow in ‘Supplemetary_Text’ file).</p></list-item><list-item><p id="Par14">A Pathway analysis workflow to score and rank the pathways produced through Retrosynthesis step based on multiple criteria (cf. Pathway analysis workflow in ‘Supplemetary_Text’ file). Some criteria necessitated the development of specific methods for pathways thermodynamics (cf. Thermodynamics in Methods section) and theoretical product flux calculation (cf. Flux Balance Analysis with Fraction of Reaction in Methods section). Pathway scoring is performed via Machine Learning using a training set of pathways extracted from literature and pathways validated by pathway engineering experts (cf. subsection Benchmarking workflows with literature data and expert validation trial).</p></list-item><list-item><p id="Par15">Two Genetic design and engineering workflows that produce assembly plans for plasmids encoding the pathways generated by the Retrosynthesis or Pathway analysis workflows (cf. Genetic design and engineering workflows in ‘Supplemetary_Text’ file). The first workflow generates plans for Golden Gate<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, Gibson<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, and Ligation Chain Reaction (LCR)<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> assembly methods. It also includes Design of Experiment (OptDoE tool) for combinatorial experimental design. The second workflow (BASIC assembly) generates plans for the Biopart Assembly Standard for Idempotent Cloning (BASIC) technique<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. This workflow provides a direct link between machine-enabled design and automated assembly. It takes as input a pathway and generates a script to operate an Opentrons liquid handler robot performing assembly and chassis transformation.</p></list-item></list></p>
      <p id="Par16">In the reminder of the paper, a metabolic pathway is a succession of chemical reactions transforming reactants into products, while a construct is the assembly of genetic parts that encodes a metabolic pathway. Several constructs with different enzyme and regulatory sequences can encode for the same pathway. The Retrosynthesis and Pathways analysis workflows generate annotated SBML files describing pathways (cf. Pathway annotation in Methods section), which are taken as input to the Genetic design and engineering workflows to produce constructs, i.e., plasmids encoded in SBOL format along with assembly plans (in CSV files) and liquid handler instructions (python scripts directly executable by Opentrons).</p>
    </sec>
    <sec id="Sec5">
      <title>Benchmarking workflows for Lycopene production</title>
      <p id="Par17">The <italic>Retrosynthesis</italic> workflow was run at the Genoscope laboratory (Paris region, France) for the production of lycopene in <italic>E. coli</italic>. We used iML1515<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> as a model for <italic>E. coli</italic>. The retrosynthetic map was composed of 12 unique compounds and 7 unique reactions, resulting in 3 “master” pathways (cf. Retrosynthesis from target to chassis in Methods section). Only the 10 best pathways were kept per master pathway, after reaction completion with cofactors and removal of duplicates only 9 pathways remained. Additional details are provided in the Supplementary file ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’.</p>
      <p id="Par18">The Pathway Analysis workflow was run at the University Polytechnic of Valencia, Spain. The workflow took as inputs the list of nine pathways generated by the Retrosynthesis workflow. Results are shown in Fig. <xref rid="MOESM1" ref-type="media">S6</xref> in the ‘Supplementary_Text’ and ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’ files. The top-ranked pathway was composed of 3 reactions with EC numbers listed from chassis metabolites to target: 2.5.1.29, 2.5.1.96 and 1.3.99.31.</p>
      <p id="Par19">The Genetic design and engineering workflow for BASIC assembly was run at two different locations: Paris (Micalis Institute) and London (Imperial College). In both cases, as design input we used the top lycopene ranked pathway predicted by the Pathway analysis. Constraining the enzyme search within the organism <italic>Pantoea ananas</italic>, enzymes CrtE (UniProt ID: P21684), CrtB (P21683), and CrtI (P21685) were predicted by the Selenzyme tool for the three-reaction pathway (Fig. <xref rid="MOESM1" ref-type="media">S8</xref> in the ‘Supplementary_Text’ file and ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’ Supplementary file). A total of 88 construct designs were automatically generated by the genetic design and engineering BasicDesign tool. The designs were coded in a CSV file that was fed to DNA-Bot, which was executed in Paris and London with different labware identifiers and associated parameters (cf. Genetic design and engineering workflow execution in Methods). In both laboratories, DNA-Bot generated four executable python scripts (clip reactions, purification, assembly and strain transformation) that were run on Opentrons robots. Additional information can be found in the Supplementary file ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’.</p>
      <p id="Par20">Following the executable scripts produced by the Genetic design and engineering workflow the three genes of the pathway (<italic>crtE</italic>, <italic>crtB</italic> and <italic>crtI</italic>) were assembled in varying gene order in an operon, together with six different RBS-linkers (Fig. <xref rid="Fig1" ref-type="fig">1.a</xref>). Each of these linkers held a ribosome-binding site of high or low strength for each of the three genes (cf. Supplementary file ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’); the remaining untranslated region upstream of the RBS provides the overlap sequence that drives the assembly. For consistent RBS context the three untranslated sequences of the linkers were always upstream of the same gene in the assembly. The pathway operon was expressed using one of two different promoters (medium strength PJ23105 and low strength PJ23116).<fig id="Fig1"><label>Fig. 1</label><caption><title>Automated construction of 88 distinct plasmids coding for lycopene pathway operons containing genes in different orders, with varying promoters and RBSes.</title><p><bold>a</bold> Plasmids coding for lycopene genes were assembled using the BASIC method (with DNA linkers). Genes in the lycopene pathway, <italic>crtE</italic>, <italic>crtB</italic>, and <italic>crtI</italic> (parts 3, 4, and 5), were assembled in an operon with UTR-RBS linkers containing different RBSes. The promoter (part 2) and the 3-gene operon were assembled into a backbone with p15A origin of replication (ORI) and chloramphenicol resistance gene (Cmp-R). The assembled parts were flanked by methylated linkers that recapitulate BASIC prefix and suffix (LMP and LMS). <bold>b</bold> Number of constructs with successful transformant colonies and their color are reported from Micalis Institute, Paris, and Imperial College, London. Number of constructs common to both laboratories are in the intersection. Data are from spotting 10 µL of transformation reactions by Opentrons (left) and from spotting 100 µL manually or 40 µL by Opentrons (right) on LB plates. <bold>c</bold> Count-plots show the number of constructs with successful colonies, grouped by position and gene (details in Supplementary file ‘Dataset <xref rid="MOESM5" ref-type="media">1</xref>’). Results are from Paris (left), from London (right), and in common (middle). Constructs have a weaker promoter (top) or stronger promoter (bottom). The RBSes are differentiated by colors. The genes’ positions in the operon are indicated on the x-axis. Means of the number of constructs for each promoter are shown by dashed lines. <bold>d</bold> Lycopene measurement (mg of lycopene per gDCW) from different constructs from both laboratories. Types of RBSes and promoters, and gene orders are indicated. E: <italic>crtE</italic>, B: <italic>crtB</italic>, I: <italic>crtI</italic>. Promoters and terminators are shown at the extremities. <bold>e</bold> Examples of red and white colonies (top), pellet preparation (middle) and acetone extracted lycopene (bottom). Source data are provided in the ‘Source Data’ file.</p></caption><graphic xlink:href="41467_2022_32661_Fig1_HTML" id="d32e741"/></fig></p>
      <p id="Par21">In both laboratories (Paris and London) the scripts were used for the 88 constructs and to spot 10 µL of the transformed cells (<italic>E. coli</italic> DH5-alpha) on a rectangular LB-agar plate (cf. Lycopene production in Methods section). Of these, only 30 (22 red + 8 white) and 33 (21 red + 12 white) constructs gave transformant colonies at Paris and London respectively (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). However, only 12 (11 red + 1 white) of these transformants were common across the two laboratories, suggesting that 10 µL may be too low a volume to spot for these transformations. To test if more transformants can be obtained by increasing this volume, we manually plated 100 µL of the transformed cells in Paris and repeated the spotting step in London using 40 µL on a 12-well plate (cf. Lycopene production in Methods). Of the 88 constructs, this time transformants were obtained for 51 (41 red + 10 white) and 63 (49 red + 14 white) constructs at Paris and Imperial, respectively, including 36 (33 red + 3 white) constructs in common.</p>
      <p id="Par22">An analysis of the number of successful transformants obtained in the two laboratories for the different combinations of promoter, RBS, and gene order indicates a preference for the weaker J23116 promoter (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). Overexpression of the three pathway genes from a strong promoter may be too toxic for the cell, resulting in overall reduced fitness and consequently fewer successful transformants. Four transformant colonies with visibly different levels of red color (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>) were used for acetone extraction of lycopene at Micalis (cf. Genetic design and engineering workflow execution in Methods), and similarly eight colonies were used for lycopene extraction at Imperial. The highest lycopene production was obtained for construct G6 (4.389 mg/gDCW), a yield comparable to those from <italic>E. coli</italic> in similar conditions (5.69 mg/gDCW from <italic>E. coli</italic> DH5-alpha in 2xYT<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> and 6.52 mg/gDCW from <italic>E. coli</italic> ATCC 8739 in LB<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>). In both the weak (J23116) and the high (J23105) promoter groups, low lycopene production was observed from constructs with more than one high-strength RBS (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). When comparing the constructs with the same gene order, for example <italic>crtE-crtI-crtB</italic> (H10, B9), <italic>crtB-crtI-crtE</italic> (B11, D2), or <italic>crtI-crtE-crtB</italic> (C9, D8), constructs with more low-strength RBSes exhibited higher lycopene production. There was also an apparent preference for the <italic>crtI-crtE-crtB</italic> (G6, C9, D8) among the highest producing constructs. Taken together, these data indicate that maximizing the expression of pathway genes can increase cellular burden, resulting in lower pathway productivity.</p>
    </sec>
    <sec id="Sec6">
      <title>Benchmarking workflows with literature data and expert validation trial</title>
      <p id="Par23">Criteria computed by the Pathway analysis workflow like target product flux, thermodynamic feasibility, pathway length, and enzyme availability score inform the user as to the best potential candidate pathway to produce a compound of interest. These criteria can be combined in a global score value. To that end, we developed a machine learning scoring tool (cf. Machine Learning Global Scoring in Methods) taking training data from literature and a validation trial conducted by metabolic engineering experts (cf. Acknowledgement section for the list of experts enrolled). The process is summarized in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, the literature benchmarking and expert trial results are provided in the following subsections.<fig id="Fig2"><label>Fig. 2</label><caption><title>Scoring Galaxy-SynBioCAD predicted pathways with literature pathways and expert validation data.</title><p><bold>a</bold> Pathways for different targets and different hosts are extracted from literature (cf. Literature data benchmarking subsection), this is illustrated here for production of phenol in <italic>E. coli</italic>. <bold>b</bold> Galaxy-SynBioCAD workflows are run on the literature targets and hosts. <bold>c</bold> A collection of Galaxy-SynBioCAD generated pathways is compiled. Pathway ‘A’ producing phenol in <italic>E. coli</italic> from tyrosine is highlighted. <bold>d</bold> The Galaxy-SynBioCAD generated pathways are compared with the literature pathways using a matching algorithm (cf. ‘Supplementary_Text’ file). The plot shows for each literature pathway the best matching pathways among all Galaxy-SynBioCAD generated pathways. Pathways having a matching score above 0.5 are identical (similarity of 1) to literature pathways as far as main substrate and products are concerned. The raw data can be found in Supplementary file ‘Dataset <xref rid="MOESM6" ref-type="media">2</xref>’, tab ‘literature_matching_score’. <bold>e</bold> Galaxy-SynBioCAD generated pathways are evaluated by metabolic engineer experts whose task is to select in batches of 5 generated pathways which ones are valid (cf. Expert validation trial benchmarking subsection). <bold>f</bold> Valid pathways according to experts and pathways matching literature are added to a training set of labeled pathways. <bold>g</bold> The set of labeled pathways is used to train a classifier printing out a machine learning score to assess if a given pathway is valid or not (cf. Machine Learning Global Scoring in Methods section). The figure plots the results obtained for all pathways generated by Galaxy-SynBioCAD. The raw data, including the training set, can be found in the Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’. Using a machine learning global score threshold of 0.5, the accuracy retrieving literature of expert labeled pathways is 0.91 with a false positive rate of 0.10 in 4-fold cross validation (cf. Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’, tab ‘Pathway_PredictedScore’). Source data are provided in the ‘Source Data’ file.</p></caption><graphic xlink:href="41467_2022_32661_Fig2_HTML" id="d32e846"/></fig></p>
      <p id="Par24"><bold>Literature data benchmarking.</bold> A list of 77 pathways corresponding to 60 expressed compounds in engineered organisms (<italic>E. coli, S. cerevisiae</italic>, and <italic>P. putida</italic>) was collected from the literature (cf. Supplementary file ‘Dataset <xref rid="MOESM6" ref-type="media">2</xref>’). For each of the 77 collected pathways and each heterologous pathway reaction, we compiled the EC number of the reaction along with the corresponding substrates and products. Each target compound within that list was used to run the Retrosynthesis and Pathways analysis workflows to generate a collection of 5874 predicted pathways that produced the same target molecule in the same host organism as those reported in the literature. Following that, the predicted collection of pathways were compared with their corresponding literature pathways using a matching algorithm described in the ‘Supplementary_Text’ file. Figure <xref rid="Fig2" ref-type="fig">2d</xref> shows for each literature pathway, the predicted pathway with the highest matching score (raw data is in Supplementary file ‘Dataset <xref rid="MOESM6" ref-type="media">2</xref>’). Any pathway generated by Galaxy-SynBioCAD is labeled ‘literature pathway’ if its score is above 0.5 and that pathway is added to the training set of a machine learning model predicting global score (Fig. <xref rid="Fig2" ref-type="fig">2f, g</xref>).</p>
      <p id="Par25"><bold>Expert validation trial benchmarking.</bold> Pathways generated by Galaxy-SynBioCAD should not be discarded even when they do not appear in the literature, for the obvious reason that not all pathways have been engineered for the 60 targets of our literature benchmarking. To palliate this shortcoming, we generated a set of 7919 predicted pathways for 80 (target, chassis) pairs using the Retrosynthesis and Pathway analysis workflows. The set included the 5874 pathways generated for our literature benchmarking along with 2045 additional pathways corresponding to 20 additional (target, chassis) pairs taken from the LASER database<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, which includes some pathways from <italic>B. subtilis</italic>. We next spliced the set in batches of 5 pathways synthesizing the same target in the same chassis. The predicted pathways best matching the literature pathways (when known) were included and the 4 remaining pathways were drawn randomly. We next recruited 40 experts in the metabolic engineering community (see Acknowledgement section) and asked them to select valid pathways in the list they received. To help the selection process, the experts received a clickable map of the 5 pathways (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>) where they could collect information on compounds and reactions, reaction and pathway thermodynamics, a ranked list of enzymes catalyzing each reaction, and reaction and pathway production fluxes. An example of such a map can be found on the Galaxy-SynBioCAD portal. The results were recorded and merged with the literature benchmarking results using an OR function for identical pathways. At the end of this process, among the 7919 pathways, 754 were labeled positive either because their matching score with a literature pathway was above 0.5 or because they were selected as feasible to engineer by the experts (cf. Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’).</p>
      <p id="Par26">Using the literature and expert validated pathways, we developed a machine learning model whose purpose was to evaluate if any given pathway is a valid one or not. To that end, we used a classifier (cf. Machine Learning Global Scoring in Methods section), which returned a global score for each queried pathway. The global score distribution for the dataset of 7919 pathways is given in Fig. <xref rid="Fig2" ref-type="fig">2g</xref> (raw data are in Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’). The classifier exhibited excellent performances with an average cross-validation accuracy of 0.91.</p>
      <p id="Par27">The machine learning global scoring process was used to rank the top 50 Galaxy-SynBioCAD pathways generated for 60 target molecules taken from our literature pathway training set. More precisely, a global score was calculated for all SynBioCAD generated pathways using machine learning. Concomitantly, literature or expert selected pathways were identified using the matching algorithm described in the ‘Supplementary_Text’ file. Results are shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref> where each row is a ranked list of collections of SynBioCAD generated pathways for a given target molecule in a given chassis. Literature or expert selected pathways are flagged with a black square and pathways are ranked according to the global score aforementioned. Overall, we find that in 83% cases, the literature or expert selected pathways have a score in the top 10 scores of all the pathways generated for the same target and chassis. The number rises to 94% in retrieving literature or expert validated pathways among the top 50 machine learning scored pathways.<fig id="Fig3"><label>Fig. 3</label><caption><title>Ranking predicted pathways with machine learning global score.</title><p>The color code on the right side shows the machine learning global score (from 1 top to 0). The black boxes show the location of the literature or expert selected pathways for a set 60 literature target engineered in <italic>E. coli</italic> (*), <italic>S. cerevisiae</italic> (**) or <italic>P. putida</italic> (***). If a row does not contain a black box, then the literature or expert selected pathway is not found within the first 50 scored pathways. The numbers listed on the right side are the total numbers of pathways generated by the Galaxy-SynBioCAD workflows. The data used to generate the figure can be found in Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’, tab ‘Lit_Pathway_Rank_ML’. Source data are provided in the ‘Source Data’ file.</p></caption><graphic xlink:href="41467_2022_32661_Fig3_HTML" id="d32e922"/></fig></p>
      <p id="Par28">To assess the advantage of making use of a machine learning scoring schema, we computed a direct score based on (i) the inverse of the pathway length (favoring shorter pathway), (ii) the opposite normalized pathway free energy (favoring high negative values), (iii) the normalized averaged enzyme availability score, and (iv) the normalized FBA calculated product flux value. All these values were calculated using the Pathway analysis workflow (addition information are found in Table <xref rid="Tab3" ref-type="table">3</xref> in Methods section). A direct score calculation, which does not make use of machine learning, can simply be obtained summing the above four parameters. Results are presented in the Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’ (tab ‘Lit_Pathway_Rank_noML’) where 58% of the identified literature/expert pathways are found within the top 10 scored pathways generated by Galaxy-SynBioCAD, this number is lower than the one obtained when using machine learning (83%).</p>
    </sec>
  </sec>
  <sec id="Sec7" sec-type="discussion">
    <title>Discussion</title>
    <p id="Par29">We have presented several Galaxy workflows to design and engineer pathways in host organisms. These workflows have been built using 25 different computational tools. Chaining the tools together to form workflows was made possible only because the input and output of each tool were standardized. As far as standardization is concerned, we chose community adopted standards like InChI and SMARTS for compounds and reactions, SBML for pathways and strains, and SBOL for genetic constructs.</p>
    <p id="Par30">We illustrated our workflows by designing and engineering a library of 88 pathway variants designed to produce lycopene in <italic>E. coli</italic> DH5-alpha on Opentrons liquid handlers. The workflows were executed at four different locations demonstrating the ability of the Galaxy-SynBioCAD portal to run workflows (including robot drivers with different labwares) at different sites, and consequently the possibility of completing multi-partners design and engineering projects.</p>
    <p id="Par31">There are many standard protocols for biological engineering but as argued elsewhere<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, written protocols without practical guidance can lead to problems, as protocols often contain ambiguities or rely on tacit knowledge. Here the possibility of running several times the same workflow that incorporates automated experiments provides a systematic way to quantify reproducibility (cf. Fig. <xref rid="Fig1" ref-type="fig">1</xref>).</p>
    <p id="Par32">To assess the validity of our generated pathways, we used a double-blind testing strategy performed by a pool of participants. In that strategy, used previously to evaluate synthesis planning<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, neither the participants nor the conductors are aware of the origin of the pathways, and the participants are asked to flag pathways they deemed valid without having explicit information on pathways found in the literature. We applied this approach to develop a machine learning based scoring function reaching high predictability when ranking pathways.</p>
    <p id="Par33">The Galaxy-SynBioCAD portal presented in this paper, proposes a set of synthetic biology and metabolic engineering computational tools in a Galaxy framework<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. We chose Galaxy as our workflow system because the tools found in the ToolShed<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> have reached way beyond genome analysis for which Galaxy was originally developed. Just by focusing on the tool categories relevant to our study, one can cite proteomics, transcriptomics, metabolomics, flow cytometry analysis, and computational chemistry. Several communities are using Galaxy and many papers can be found online for omics (752 publications are found as of 16 February 2022) microbiome (380 publications), diseases like cancer (386 publications), and drug design and discovery (96 publications). At our request, a new Galaxy category named ‘Synthetic Biology’ was created, currently comprising 25 tools stored in the ToolShed.</p>
    <p id="Par34">The offering in Galaxy-SynBioCAD focuses on providing tools for pathway design and engineering. However, as Galaxy-SynBioCAD is a community effort, we anticipate our toolset will grow. Regarding pathway design tools, many of the software products listed in the introduction could be considered to be added to the portal. In particular, strain design including knockout genes to maximize targeted product fluxes could easily be implemented via the flux balance analysis tools. Additionally, there are already Galaxy workflows to take up and analyze metabolomics flow cytometry data in the ToolShed<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, and these workflows could directly be incorporated into the portal to deal with data generated in the ‘Test’ step of the synthetic biology Design-Build-Test-Learn (DBTL) cycle. As mentioned in the introduction, several open-source software products deposited in GitHub<sup><xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup> could address the ‘Build’ step and eventually provide drivers to automated constructions using different robotic workstations beyond those provided by Opentrons. Regarding the ‘Learn’ step in DBTL, the OptDoE tool could easily be adapted to propose new designs as it was done in Carbonell et al.<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Other approaches to be considered are methods that make use of active machine learning as in Borkowski et al.<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Although all design examples provided in the current paper are for engineering pathways in host organisms, because of the recent development of models (similar to genome scale models) for cell-free systems<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, one can also consider adapting the portal for design and engineering in cell-free.</p>
    <p id="Par35">All of the above-suggested additions could be implemented in our portal with relatively small efforts (cf. Tools design and integration process in ‘Supplementary_Text’ file). There are other applications that could be envisioned beyond pathway design and engineering. For instance, as shown in Delépine et al.<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> retrosynthesis software can easily be adapted to design biosensors. Such an adaptation has been proposed as a Galaxy-SynBioCAD workflow to predict and implement biosensors for the detection of various metabolites using the hydrogen peroxide compound as a metabolic hub, such that the metabolite signals are transduced to hydrogen peroxide before being sensed by the OxyR transcription factor<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Tools for genetic logic circuits engineering could also be considered. Also, as the cell resources consumption due to the level of expression of heterologous genes are not considered in the global score of a pathway, integrating in the overall design pipeline a tool enabling the prediction of the metabolic burden of genetic constructs based on enzyme expression levels would be of great interest and should be targeted for the future.</p>
  </sec>
  <sec id="Sec8">
    <title>Methods</title>
    <sec id="Sec9">
      <title>Retrosynthesis from target to chassis</title>
      <p id="Par36">Typically, the target compound, also named “source compound” is the compound of interest one wishes to produce, while the precursors are usually compounds that are natively present in a chassis strain. In the present implementation, the target can be any chemical that could be described by an InChI, and the chassis should be a metabolic model described in an SBML file. Starting from the source compound at the first iteration, reaction rules matching the chemical structure of the source are applied and newly predicted chemicals are generated. Reaction rules are generic descriptions of (bio)chemical reactions encoded into the community standard SMARTS<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. The use of reaction rules allows estimating the outcomes of chemical transformations based on the generalization of reactions available in knowledge databases such as BRENDA<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, MetaCyC<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, Rhea<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, or MetaNetX<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. The degree of generalization is controlled by describing the surrounding environment of the reaction center up to a given diameter as described in Duigou et al.<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. To ensure the accuracy of the predicted transformations that will outcome from the reaction rules, the RetroRules dataset provided by the Galaxy RetroRules tool has been validated by (i) checking that rules allow to reproduce the template reactions, and (ii) checking that results obtained by decreasing diameters are supersets of results obtained with higher diameters. Only the reaction rules that successfully passed the 2 checks are retained. The validation of this dataset has a success rate of 99.3%.</p>
      <p id="Par37">For each reaction rule, a score is calculated based on the ability to retrieve enzyme sequences catalyzing substrate to product transformations, the method is detailed in Delépine et al.<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Newly produced chemicals are scanned and kept for the next iteration if they are not within the set of available precursors. In that way, a new iteration is started using the previously collected chemicals as the new source set. The iterative process stops when either no new chemicals are discovered or the predefined number of steps is reached. RetroPath2.0 carries out this task.</p>
      <p id="Par38">The retrosynthesis tools RetroPath2.0 and RP2Paths output a set of pathways composed by chemical transformations based on reaction rules. To obtain reactions, we have to re-build them from template reactions which have been used to generate the rules. In addition, within a pathway one single chemical transformation can reference multiple rules. Such pathways will be called master pathways. For each master pathway, the algorithm takes each transformation and creates one fork per reaction rule referenced. Then for each reaction rule, again the algorithm creates a new fork per template reaction used to build the current rule. The enumeration of all forks create a set of slightly different pathways (made of chemical reactions) for one master pathway. To perform the enumeration, datasets from RetroRules and MetaNetX are used. The reaction completion tool (rpCompletion) takes as input the CSV outputs of RP2paths and RetroPath2.0 and produces a collection of annotated SBML files. Those SBML files are “enriched” with additional information that are not stored as part of the normal SBML schema (cf. Pathway annotation section).</p>
    </sec>
    <sec id="Sec10">
      <title>Pathway annotation</title>
      <p id="Par39">Some results generated by the workflow produced in this study cannot be readily stored in the SBML files natively (informations about chemical reactions and species, thermodynamic and fluxes properties, as well as pathway information).</p>
      <p id="Par40">Using the Minimal Information Required In the Annotation of Models (MIRIAM) conventions, one can store within the SBML file information that instructs the user on the provenance of the reactions and chemical species within the model by cross-references to a wide range of databases. However, this needs a third-party database lookup to match the database ID with its structural information. In this work, intermediate products are generated ad hoc references and may not necessarily have database entries whereas some other information cannot be contained under the MIRIAM annotations as it is: SMILES, InChI, InChIKey for chemical species, reaction rule ID (RetroRules ID), associated template reaction ID, and rule score based on the expected enzyme availability.</p>
      <p id="Par41">As such, we elected to enrich the SBML format in such a way that our information can be stored directly within the SBML file without breaking any standard of the original file. Because SBML files are based on XML, new XML annotations are created outside the standard scope of an SBML file and thus are ignored by any standard SBML readers<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. As a result, this enriched file format (denoted rpSBML) is fully compliant with SBML version 3 specifications.</p>
      <p id="Par42">Standard SBML extensions are also used in this project. The “groups” package is used to link the heterologous reactions and chemical species to identify them easily, as well as classifying the chemical species that are main actors in an heterologous pathway<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. The SBML FBA package is used to define the FBA simulation conditions<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. The tools also adhere to the MIRIAM annotation standard for the cross-references of chemical species to public databases<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p>
    </sec>
    <sec id="Sec11">
      <title>Flux balance analysis with fraction of reaction</title>
      <p id="Par43">We need metrics to rank heterologous pathways, this is why we developed an in-house Flux Balance Analysis (FBA) objective to simulate the flux of a target while considering the burden that the production of the target would cause on the cell. Under such simulation conditions, the analysis that returns a low flux may be caused by the starting native compound itself not having a high flux, or the cofactors required having a low flux, while the pathways with high flux would be caused by both the starting compound and the cofactors being in abundance. In either case, bottlenecks that limit the flux of the pathway may be identified and pathways that do not theoretically generate high yields can be filtered out. Furthermore, the production of heterologous molecules in an organism often causes a burden on the growth of the cell. To emulate such a condition, we use the method named ‘fraction of reaction’. We first perform FBA (with COBRApy<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>) for the biomass reaction and record its flux. The upper and lower bounds of the biomass reaction are then set to the same amount, defined as a fraction of its previously recorded optimum. This ensures that any further FBA solution would have a fixed biomass production regardless of the conditions set for further analysis.</p>
      <p id="Par44">The tool optimizes the target molecule and records the flux directly to the SBML file and all changed bounds are reset to their original values before saving the file. It is important to note that orphan chemical species (those which are only consumed or produced by the metabolic pathway) are ignored. Such species are documented in the SBML file within the group named <italic>rp_fba_ignored_species</italic>.</p>
    </sec>
    <sec id="Sec12">
      <title>Thermodynamics</title>
      <p id="Par45">Thermodynamics is critical in synthetic pathway design by providing quantitative indicators to determine best metabolic pathways among a set of predicted ones. Thus, one can perform thermodynamic analysis to know whether a reaction direction of a pathway is feasible in physiological conditions.</p>
      <p id="Par46">In this work, we performed thermodynamic analysis for species, reactions and pathways. We use eQuilibrator<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> to compute the formation energy of chemical species and the Gibbs free energy for each chemical reaction and the heterologous pathway.</p>
      <p id="Par47">For each species involved in a heterologous pathway, the first challenge is to find the corresponding compound in the eQuilibrator database. To find the right compound, we try to exactly match species ID, InChIKey, InChI or SMILES and stop with the first hit. Then, if no compound is found, in the last resort, the first part of species InChIKey is looked for within the eQuilibrator cache and when the result (a list) is not empty, the first compound is taken. If species have no known structure neither in eQuilibrator database nor in any public one, the user has the possibility to specify substitution for identifier, InChI and InChIKey for these species. This substitution is documented in the SBML file with the group named <italic>rp_thermo_substituted_species</italic>. If a species has no known structure and is not substituted, then the reaction which involves this species will not have a thermodynamics value. Conversely thermodynamics can be computed by eQuilibrator for all reactions for which all species have been identified.</p>
      <p id="Par48">At the level of the pathway, we build a global pseudo-reaction linking chassis substrates to the target molecule and we compute thermodynamics with the eQuilibrator engine for the global pseudo-reaction.</p>
      <p id="Par49">Building the global pseudo-reaction requires finding the appropriate stoichiometric coefficients such that the intermediate compounds of the pathway cancel out. A linear optimization program (Eq. <xref rid="Equ1" ref-type="">1</xref>) can be set to find the stoichiometric coefficients. The program can be solved using SciPy<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> with a simplex algorithm.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{ll}\hfill\max &amp; {c}^{T}x\\ such\,that &amp; Ax=0\\ \hfill and &amp; 1\le x\end{array}$$\end{document}</tex-math><mml:math id="M2"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mi>max</mml:mi></mml:mtd><mml:mtd columnalign="left"><mml:msup><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:mi>x</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mspace width="0.25em"/><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi></mml:mtd><mml:mtd columnalign="left"><mml:mi>A</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi></mml:mtd><mml:mtd columnalign="left"><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mi>x</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="41467_2022_32661_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> is the objective function, <italic>A</italic> the stoichiometric matrix, and <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x$$\end{document}</tex-math><mml:math id="M4"><mml:mi>x</mml:mi></mml:math><inline-graphic xlink:href="41467_2022_32661_Article_IEq1.gif"/></alternatives></inline-formula> the unknown stoichiometric coefficient multipliers.</p>
      <p id="Par50">As an example, let’s consider the following 3-reaction set:<disp-formula id="Equa"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Rx}{n}_{1}	:{MNXM}188+{MNXM}4+{MNXM}6+3\,{MNXM}1 \\ 	\to {CMPD}4+{CMPD}3+{MNXM}13+{MNXM}15+{MNXM}5$$\end{document}</tex-math><mml:math id="M6"><mml:mi>R</mml:mi><mml:mi>x</mml:mi><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>:</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>188</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>6</mml:mn><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>1</mml:mn><mml:mo>→</mml:mo><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>3</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>13</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>15</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>5</mml:mn></mml:math><graphic xlink:href="41467_2022_32661_Article_Equa.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equb"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Rx}{n}_{2}:{MNXM}4+2\,{CMPD}3 \to 2\,{MNXM}1+{TARGET}$$\end{document}</tex-math><mml:math id="M8"><mml:mi>R</mml:mi><mml:mi>x</mml:mi><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>:</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>3</mml:mn><mml:mo>→</mml:mo><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>G</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:math><graphic xlink:href="41467_2022_32661_Article_Equb.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${Rx}{n}_{3}:{MNXM}4+{MNXM}6+3\,{CMPD}4\to {MNXM}13+{MNXM}5$$\end{document}</tex-math><mml:math id="M10"><mml:mi>R</mml:mi><mml:mi>x</mml:mi><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>:</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>6</mml:mn><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:mspace width="0.25em"/><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>4</mml:mn><mml:mo>→</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>13</mml:mn><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>5</mml:mn></mml:math><graphic xlink:href="41467_2022_32661_Article_Equc.gif" position="anchor"/></alternatives></disp-formula>where <italic>MNXM</italic> are species IDs from MetaNetX, CMPD are intermediate species within the heterologous pathway and not present in the chassis organism, and TARGET is the product of interest. We note that <italic>Rxn</italic><sub><italic>2</italic></sub> is the reaction to retain and <italic>CMPD3</italic> and <italic>CMPD</italic><italic>4</italic> are species to remove as intermediate compounds. Thus, the parameters of linear solver are:<disp-formula id="Eque"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin {array}{ccc}{R}_{1}&amp;{R}_{2}&amp;{R}_{3}\end{array}\hskip-4pt\\ c=\left(\begin {array}{ccc}0&amp;1&amp;0\end{array}\right)$$\end{document}</tex-math><mml:math id="M12"><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>0</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="41467_2022_32661_Article_Eque.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equg"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin {array}{ccc}{R}_{1}&amp;{R}_{2}&amp;{R}_{3}\end{array}\hskip4pt\\ A=\begin{array}{c}{CMPD}3\\ {CMPD}4\end{array}\left[\begin{array}{ccc}1 &amp; -2 &amp; 0\\ 1 &amp; 0 &amp; -3\end{array}\right]$$\end{document}</tex-math><mml:math id="M14"><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mi>A</mml:mi><mml:mo>=</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>3</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="center"><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mi>P</mml:mi><mml:mi>D</mml:mi><mml:mn>4</mml:mn></mml:mtd></mml:mtr></mml:mtable><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="center"><mml:mn>1</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>0</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="41467_2022_32661_Article_Equg.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par51">The solver outputs the following coefficients of reactions:<disp-formula id="Equi"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hskip10pt\begin {array}{ccc}{R}_{1}&amp;{R}_{2}&amp;{R}_{3}\end{array}\hskip-4pt\\ x=\left(\begin {array}{ccc}3&amp;1.5&amp;1\end{array}\right)$$\end{document}</tex-math><mml:math id="M16"><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="center"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:mn>3</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>1.5</mml:mn></mml:mtd><mml:mtd columnalign="center"><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="41467_2022_32661_Article_Equi.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par52">The global pseudo-reaction for the reaction sets becomes:<disp-formula id="Equj"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$	7.5\,{MNXM}1+3\,{MNXM}188+5.5\,{MNXM}4+4\,{MNXM}6\\ 	\to 4\,{MNXM}13+3\,{MNXM}15+4\,{MNXM}5+{TARGET}$$\end{document}</tex-math><mml:math id="M18"><mml:mn>7.5</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>188</mml:mn><mml:mo>+</mml:mo><mml:mn>5.5</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>6</mml:mn><mml:mo>→</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>13</mml:mn><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>15</mml:mn><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.25em"/><mml:mi>M</mml:mi><mml:mi>N</mml:mi><mml:mi>X</mml:mi><mml:mi>M</mml:mi><mml:mn>5</mml:mn><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>R</mml:mi><mml:mi>G</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:math><graphic xlink:href="41467_2022_32661_Article_Equj.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec13">
      <title>Genetic design and engineering workflow execution</title>
      <p id="Par53">From amongst the pathway predicted by the Pathway analysis workflow, the top-ranked one was selected with a score of 0.989. The search scope of the Selenzyme tool was restricted to the taxon ID of <italic>Pantoea ananas</italic>, i.e., 553 taxon ID. The combination of polycistronic constructs was built using 2 constitutive promoters (PJ23105 and PJ23116), 2 RBS linkers (A03 with a translation initiation rate of 46%, and A04 of 3%), 1 backbone (BASIC_SEVA_36_CmR-p15A.1) and enabling CDS permutation, resulting in a theoretical maximal number of constructs of 96 for 3 CDS. The labware IDs and parameters used with DNA-Bot parameters are listed in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>. Additional changes in the purification step were needed because the 2 labs own different versions of the magnetic module (generation 1 vs generation 2). An updated version of the original DNA-Bot tool<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> was developed to be fully compatible with the Opentrons APIv2 and enabling a command-line interface, whilst retaining the option of using an enhanced GUI for direct user control.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Labware IDs used at Imperial College (London) and Micalis Institute (Paris) laboratories</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Description</th><th>London</th><th>Paris</th><th>Used in</th></tr></thead><tbody><tr><td>P20 single channel pipette</td><td>p20_single_gen2</td><td>p20_single_gen2</td><td>Steps 1, 3, and 4</td></tr><tr><td>P300 multi channels pipette</td><td>p300_multi_gen2</td><td>p300_multi_gen2</td><td>Steps 2 and 4</td></tr><tr><td>Opentrons 4-in-1 tubes rack for 1.5 ml eppendorf tubes</td><td>e14151500starlab_24_tuberack_1500ul</td><td>opentrons_24_tuberack_eppendorf_1.5ml_safelock_snapcap</td><td>Steps 1, 3, and 4</td></tr><tr><td>Opentrons 10 μL tips rack</td><td>opentrons_96_tiprack_20ul</td><td>tipone_3dprinted_96_tiprack_20ul</td><td>Steps 1, 3, and 4</td></tr><tr><td>Opentrons 300 μL tips rack</td><td>opentrons_96_tiprack_300ul</td><td>tipone_yellow_3dprinted_96_tiprack_300ul</td><td>Steps 2 and 4</td></tr><tr><td>96-well rigid PCR plate (clip reactions and transformation steps)</td><td>4ti0960rig_96_wellplate_200ul</td><td>green_96_wellplate_200ul_pcr</td><td>Steps 1 and 4</td></tr><tr><td>96-well rigid PCR plate (purification and assembly steps)</td><td>4ti0960rig_96_wellplate_200ul</td><td>black_96_wellplate_200ul_pcr</td><td>Steps 2 and 3</td></tr><tr><td>Agar plate (transformation step)</td><td>nuncomnitraysingle_1_wellplate_35000ul corning_12_wellplate_6.9ml_flat</td><td>thermoomnitrayfor96spots_96_wellplate_50ul</td><td>Step 4</td></tr><tr><td>Reservoir plate 21 mL 12 channels</td><td>4ti0131_12_reservoir_21000ul</td><td>citadel_12_wellplate_22000ul</td><td>Step 2</td></tr><tr><td>96 deep well plate 2 mL wells</td><td>4ti0136_96_wellplate_2200ul</td><td>transparent_96_wellplate_2ml_deep</td><td>Step 2</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>DNA-Bot parameters that differ between Imperial College (London) and Micalis Institute (Paris) laboratories</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Step</th><th>Parameter</th><th>London</th><th>Paris</th></tr></thead><tbody><tr><td rowspan="8">Purification step</td><td>magdeck_id</td><td>magdeck</td><td>magnetic module gen2</td></tr><tr><td>magdeck_height</td><td>20</td><td>10.8</td></tr><tr><td>settling_time</td><td>2</td><td>6</td></tr><tr><td>drying_time</td><td>5</td><td>15</td></tr><tr><td>elution_time</td><td>2</td><td>5</td></tr><tr><td>wash_time</td><td>0.5</td><td>0.5</td></tr><tr><td>bead_ratio</td><td>1.8</td><td>1.8</td></tr><tr><td>incubation_time</td><td>5</td><td>5</td></tr><tr><td rowspan="2">Transformation step</td><td>incubation_temp</td><td>4</td><td>8</td></tr><tr><td>incubation_time</td><td>20</td><td>30</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec14">
      <title>Lycopene production materials and methods</title>
      <p id="Par54">Lycopene genes were synthesized by Twist Bioscience, flanked by the LMP prefix and the LMS suffix sequences<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, and cloned into pTwist high copy vector (AmpR, ColE1 replication origin) using Golden Gate. The resulting storage plasmids (pTwist_High_BASIC_CrtE, pTwist_High_BASIC_CrtB, pTwist_High_BASIC_CrtI) were confirmed by sequencing.</p>
      <p id="Par55">Storage plasmids for lycopene genes and assembly vector BASIC_SEVA_36_CmRp15A.1 were prepared using Monarch® Plasmid Miniprep Kit (Micalis) and E.Z.N.A.® Plasmid DNA Mini Kit (Imperial). The samples were diluted to 200 ng/µl ready to use in the clip reactions. Plasmids coding for the lycopene pathway variants were constructed using Biopart Assembly Standard Idempotent Cloning (BASIC) method. Five-part BASIC reactions were performed, replacing the dropout mScarlet cassette in the assembly vector (BASIC_SEVA_36_CmRp15A.1) by a promoter and three genes with appropriate linkers. A collection of neutral and functional linkers (encoding RBS sequences) is available in a ready to use 96-well plate format (<ext-link ext-link-type="uri" xlink:href="http://www.biolegio.com">www.biolegio.com</ext-link>). For this work the standard BASIC linker set (Biolegio: BBP-18500) was used.</p>
      <p id="Par56">DNA-BOT was executed as described in detail in the Genetic design and engineering workflow execution section. A clip reaction master mix was prepared by combining 3 µL of 10X NEB T4 DNA ligase buffer, 1 µL NEB BsaI-HF v2 (NEB #R3733), 1 µL T4 DNA Ligase (NEB M0202 (Micalis), or Promega M1804 (Imperial)) per 20 µL required for each reaction. The Opentrons OT-2 pipetted the 20 µL master mix for each reaction, plus 1 µL of Biolegio BASIC linkers and 1 µL of each DNA parts, together with sufficient H<sub>2</sub>O to give a total volume of 30 µL. Clip reactions were incubated in a thermocycler (Applied Biosystems) for 30 cycles (37 °C for 5 min, 16 °C for 5 min), followed by a 5 min incubation at 60 °C at Micalis. Clip reactions were incubated in Opentrons Thermocycler Module for 20 cycles (37 °C for 2 min, 20 °C for 1 min), followed by a 10 min incubation at 60 °C at Imperial. For clip reaction purification, 54 µL of Mag-Bind® TotalPure NGS magnetic beads (OMEGA BIO-TEK (Micalis) or AMPure XP (Imperial)) were added; 150 µl 70% ethanol was used during wash steps; following re-suspension in H<sub>2</sub>O, 40 µL of the eluent was transferred to a fresh well. Constructs were assembled in volumes of 15 µL using 1.5 µL of each purified clip reaction in a solution of 1X assembly buffer (CutSmart Buffer, NEB #B6004). Assembly reactions were incubated at 50 °C for 45 min in a thermocycler (Applied Biosystems (Micalis) or Opentrons Thermocycler Module (Imperial)). 20 µL of DH5-alpha Competent <italic>E. coli</italic> (NEB #C2987H, Micalis) or home-made DH5-alpha competent <italic>E. coli</italic> (Imperial) were distributed per well into 96-well plates; then, they were used for transformation reactions. In all, 5 µL of the assembly reactions were mixed with cells. Heat shock was conducted according to the manufacturer’s instructions. SOC media (125 µL) was transferred to each assembly and the reaction incubated at 37 °C for 1 h with lids off. Transformation reactions were spotted on plates (Thermo Scientific™ OmniTray™ Single well) each containing 40 mL LB-agar supplemented with 17.5 µg/mL chloramphenicol. The spotting protocol was run twice in order to spot 2 times 5 µL for each transformation reaction. The spotting step at Imperial was repeated using 40 µL of transformation reaction on a 12-well plate (Costar® 12-well 3737), each well containing 10 mL of LB_agar supplemented with 17.5 µg/mL chloramphenicol. 100 µL of each transformation reaction was plated manually on LB-agar plates containing 17.5 µg/mL chloramphenicol as well.</p>
      <p id="Par57">We selected 6 colonies at Micalis, and 8 colonies at Imperial, with different levels of red color (visual inspection) and sequenced them. This was followed by lycopene extraction from the 4 and 8 colonies, respectively, that sequenced correctly. To quantify lycopene production, 2 mL of overnight cultures grown in LB (Cm 17.5 μg/mL) were pelleted at 5000×<italic>g</italic> (10 min), washed by re-suspension in 1 mL water, re-pelleted at 5000×<italic>g</italic> (10 min), and the pellet re-suspended for extraction in 1 mL acetone. The cells in acetone were incubated at 55 °C for 20 min with continuous shaking (1300 rpm, Eppendorf Thermomixer comfort), centrifuged at 19000 x g (10 min), and the supernatant transferred to a fresh tube. Lycopene absorbance of the supernatant was measured at 474 nm using a quartz cuvette (Hellma 104.002B-QS) in a spectrophotometer (UVisco V-1100D (Micalis) or NanoDrop™ One UV-Vis (Imperial)), and the pellet was dried at 50 °C for 48 h to determine the gDCW. Absorbance (OD<sub>474</sub>) was converted to molar concentration value by dividing by 150479, the molar extinction coefficient (ε) of lycopene<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. The yield per gram dry cell weight (mg/gDCW) was calculated by dividing the absolute yield (mg) by the weight of the dried cell pellet.</p>
    </sec>
    <sec id="Sec15">
      <title>Machine learning global scoring</title>
      <p id="Par58">The purpose of the machine learning model is to predict if a given predicted pathway is a valid one or not. To that end, we developed a classifier based on the XGBoost library<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. The classifier was trained on 7919 Galaxy-SynBioCAD generated pathways (comprising 43392 reactions) used during the expert validation trial where 754 pathways were labeled positive. The training set can be found in the Supplementary file ‘Dataset <xref rid="MOESM7" ref-type="media">3</xref>’. The input features used by the classifier are given in the Table <xref rid="Tab3" ref-type="table">3</xref>, these were computed for each training pathway and each reaction within the pathways. XGBoost learn function was parameterized with a Maximum depth of a tree of 1000 and a step size shrinkage used in update to prevent overfitting of 0.3 (default value). The classifier accuracies were recorded during 4-fold cross validation.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Pathway and reaction features used by the XGBoost classifier</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Item</th><th>Format</th><th>Comment</th></tr></thead><tbody><tr><td rowspan="3">Pathway level</td><td>Chassis organisms</td><td>Integer</td><td>Taxonomy ID of the organism</td></tr><tr><td>Gibbs free energy</td><td>Float</td><td>Computed using the Thermodynamics calculations described in the Thermodynamics section</td></tr><tr><td>Fraction of reaction FBA</td><td>Float</td><td>Target flux computed by FBA (cf. Flux Balance Analysis with fraction of reaction section)</td></tr><tr><td rowspan="3">Reaction level</td><td>Reaction</td><td>4096-bit vector</td><td>A reaction is represented by its Morgan fingerprint. Fingerprint(reaction) = Fingerprint(substrate) + Fingerprint(product). Morgan fingerprints are computed using the RDKit library<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>.</td></tr><tr><td>Enzyme availability score</td><td>Float</td><td>Enzyme availability score which provided a confidence level of finding an enzyme sequence catalyzing the reaction (cf. Delépine et al.<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> for details on score computation)</td></tr><tr><td>Gibbs free energy</td><td>Float</td><td>Computed using the Thermodynamics calculations mentioned above for the provided reaction only</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec16">
      <title>Reporting summary</title>
      <p id="Par59">Further information on research design is available in the <xref rid="MOESM3" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec17">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41467_2022_32661_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41467_2022_32661_MOESM2_ESM.pdf">
            <caption>
              <p>Description of Additional Supplementary Files</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41467_2022_32661_MOESM3_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="41467_2022_32661_MOESM4_ESM.pdf">
            <caption>
              <p>Peer Review File</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="41467_2022_32661_MOESM5_ESM.xlsx">
            <caption>
              <p>Supplementary Dataset 1</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="41467_2022_32661_MOESM6_ESM.xlsx">
            <caption>
              <p>Supplementary Dataset 2</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="41467_2022_32661_MOESM7_ESM.xlsx">
            <caption>
              <p>Supplementary Dataset 3</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <app-group>
    <app id="App1">
      <sec id="Sec18">
        <title>Source data</title>
        <p id="Par63">
          <media position="anchor" xlink:href="41467_2022_32661_MOESM8_ESM.xlsx" id="MOESM8">
            <caption>
              <p>Source Data File</p>
            </caption>
          </media>
        </p>
      </sec>
    </app>
  </app-group>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>These authors contributed equally: Joan Hérisson, Thomas Duigou.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p>The online version contains supplementary material available at 10.1038/s41467-022-32661-x.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>M.d.L. and J.L.F. acknowledge funding provided by the infrastructure IBISBA1.0 (Horizon 2020 under grant agreement No 730976). J.H., T.D., K.B.K., and J.L.F. funding provided by the project ALADIN (ANR EQUIPEX+). T.D., J.L.F., and G.S.B. funding provided by BioRoBoost (Horizon 2020 under Grant agreement No 820699) and PC, NS and JLF funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and the Engineering and Physical Sciences Research Council (EPSRC) under grant ‘Centre for synthetic biology of fine and specialty chemicals (SYNBIOCHEM)’ (BB/M017702/1). N.S. acknowledges further funding from the BBSRC under grant ‘GeneORator: a novel and high-throughput method for the synthetic biology-based improvement of any enzyme’ (BB/S004955/1) and from the University of Liverpool. PC also acknowledges support from the Universitat Politècnica de València Talento Programme. VZ was supported for this work by The Edinburgh Genome Foundry funded by the BBSRC (BB/M025659/1, BB/M025640/1, and BB/M00029X/1 to Susan Rosser) and the BBSRC/MRC/EPSRC funded UK Centre for Mammalian Synthetic Biology (BB/M0101804/1 to Susan Rosser) as part of the RCUK’s Synthetic Biology for Growth programme. M.K. acknowledges funding support from INRAe’s MICA department, U. Paris-Saclay, Ile‐de‐France (IdF) region’s DIM‐RFSI, and ANR DREAMY (ANR‐21‐CE48‐003). G.S.B. and G.B. acknowledge the support of the EPSRC (EP/R034915/1). We thank Thomas Nowak (LISN, Université Paris-Saclay) for the use of the Opentrons OT-2 robot (funded by project ABIDE, CNRS), Bikash Ranjan Samal and Bibal Shahin (Micalis Institute, U. Paris Saclay) for their preliminary work of FBA and machine learning for pathway scoring. We also thank the validation trial expert panel: PhD students and master students in System and Synthetic Biology at the University of Paris Saclay (Angelo Cardoso-Batista, Léon Faure, Mostafa Mahdy, Paul Soudier and Myint Toe), the Imperial College 2020 iGEM team, the University of Manchester SYNBIOCHEM centre (in particular Rosalind Le Feuvre who dispatched the batches), Muriel Gondry (I2BC, U. Paris Saclay), Ioana Popescu (Genoscope, U. Paris Saclay), Amit Pathania and Forum Shah (Micalis Institute, U. Paris Saclay), Jacques Haiech (U. Strasbourg), Fayza Daboussi, Stéphanie Heux, Thomas Lautier, Pierre Millard, and Gilles Truan (TBI, INSA-Toulouse), Baudoin Délepine, Remi Peyraud, and Jonathan Verbeke (iMEAN Biotech), and Joan Albiol (Universitat Autònoma, Barcelona).</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>J.H., T.D., and J.L.F. designed the study and wrote the main text of the paper. J.H. and T.D. supervised code development and packaging for in-house tools. K.B.K. packaged tools and published them on Galaxy ToolShed. J.H. performed the deployment of all tools available in the Galaxy-SynBioCAD web portal as well as the Galaxy platform (web, db, tools, networking). M.d.L. encoded preliminary versions of Galaxy-SynBioCAD tools, and collected data for the literature benchmarking. OT developed the rpReport tool. N.S., P.C., T.G., and Z.A. integrated several tools in the portal with the help of M.d.L. and wrote the corresponding description. G.B., G.S.B., M.K., M.S.A., T.D., and Y.E.M. worked on the updated version of DNA-Bot. G.B., M.K., M.S.A., and Y.E.M. worked on the Experimental Benchmarking, and M.K. and M.S.A. wrote the relevant section. All authors read and approved the manuscript.</p>
  </notes>
  <notes notes-type="peer-review">
    <title>Peer review</title>
    <sec id="FPar1">
      <title>Peer review information</title>
      <p id="Par60"><italic>Nature Communications</italic> thanks Guo-Qiang Chen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. <xref rid="MOESM4" ref-type="media">Peer reviewer reports</xref> are available.</p>
    </sec>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>Source data of figures are provided in the Source Data file. The eQuilibrator database is available online at Zenodo (10.5281/zenodo.4128543) and it can be queried using the equilibrator-api python library which is available online at github (<ext-link ext-link-type="uri" xlink:href="https://gitlab.com/equilibrator/equilibrator-api">https://gitlab.com/equilibrator/equilibrator-api</ext-link>). The LASER database is available online at bitbucket (<ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/jdwinkler/laser_release/src/master/">https://bitbucket.org/jdwinkler/laser_release/src/master/</ext-link>). All other relevant data are included in the paper and in the Supplementary Text and Dataset files. <xref rid="Sec18" ref-type="sec">Source data</xref> are provided with this paper.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>All codes are accessible online following links provided in Table <xref rid="MOESM1" ref-type="media">S1</xref> found the Supplementary Text file.</p>
  </notes>
  <notes id="FPar2" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par61">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <mixed-citation publication-type="other">Appleton, E., Madsen, C., Roehner, N. &amp; Densmore, D. Design automation in synthetic biology. <italic>Cold Spring Harb. Perspect. Biol.</italic><bold>9</bold>, a023978 (2017).</mixed-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <mixed-citation publication-type="other">Nielsen, A. A. K. et al. Genetic circuit design automation. <italic>Science</italic><bold>352</bold>, aac7341 (2016).</mixed-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oberortner</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bhatia</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lindgren</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Densmore</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>A rule-based design specification language for synthetic biology</article-title>
        <source>ACM J. Emerg. Technol. Comput. Syst.</source>
        <year>2014</year>
        <volume>11</volume>
        <fpage>1</fpage>
        <lpage>19</lpage>
        <pub-id pub-id-type="doi">10.1145/2641571</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hucka</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models</article-title>
        <source>Bioinformatics</source>
        <year>2003</year>
        <volume>19</volume>
        <fpage>524</fpage>
        <lpage>531</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btg015</pub-id>
        <?supplied-pmid 12611808?>
        <pub-id pub-id-type="pmid">12611808</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Galdzicki</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2014</year>
        <volume>32</volume>
        <fpage>545</fpage>
        <lpage>550</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.2891</pub-id>
        <?supplied-pmid 24911500?>
        <pub-id pub-id-type="pmid">24911500</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Konur</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Toward full-stack in silico synthetic biology: integrating model specification, simulation, verification, and biological compilation</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2021</year>
        <volume>10</volume>
        <fpage>1931</fpage>
        <lpage>1945</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.1c00143</pub-id>
        <?supplied-pmid 34339602?>
        <pub-id pub-id-type="pmid">34339602</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>G-M</given-names>
          </name>
          <name>
            <surname>Warden-Rothman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Voigt</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>Retrosynthetic design of metabolic pathways to chemicals not found in nature</article-title>
        <source>Curr. Opin. Syst. Biol.</source>
        <year>2019</year>
        <volume>14</volume>
        <fpage>82</fpage>
        <lpage>107</lpage>
        <pub-id pub-id-type="doi">10.1016/j.coisb.2019.04.004</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hatzimanikatis</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Exploring the diversity of complex metabolic networks</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <fpage>1603</fpage>
        <lpage>1609</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bti213</pub-id>
        <?supplied-pmid 15613400?>
        <pub-id pub-id-type="pmid">15613400</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Campodonico</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Andrews</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Asenjo</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Palsson</surname>
            <given-names>BO</given-names>
          </name>
          <name>
            <surname>Feist</surname>
            <given-names>AM</given-names>
          </name>
        </person-group>
        <article-title>Generation of an atlas for commodity chemical production in Escherichia coli and a novel pathway prediction algorithm, GEM-Path</article-title>
        <source>Metab. Eng.</source>
        <year>2014</year>
        <volume>25</volume>
        <fpage>140</fpage>
        <lpage>158</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymben.2014.07.009</pub-id>
        <?supplied-pmid 25080239?>
        <pub-id pub-id-type="pmid">25080239</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Delépine</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Duigou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>RetroPath2.0: a retrosynthesis workflow for metabolic engineers</article-title>
        <source>Metab. Eng.</source>
        <year>2018</year>
        <volume>45</volume>
        <fpage>158</fpage>
        <lpage>170</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymben.2017.12.002</pub-id>
        <?supplied-pmid 29233745?>
        <pub-id pub-id-type="pmid">29233745</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Maranas</surname>
            <given-names>CD</given-names>
          </name>
        </person-group>
        <article-title>Pathway design using de novo steps through uncharted biochemical spaces</article-title>
        <source>Nat. Commun.</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>184</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-017-02362-x</pub-id>
        <?supplied-pmid 29330441?>
        <pub-id pub-id-type="pmid">29330441</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tyzack</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Ribeiro</surname>
            <given-names>AJM</given-names>
          </name>
          <name>
            <surname>Borkakoti</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Exploring chemical biosynthetic design space with transform-MinER</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2019</year>
        <volume>8</volume>
        <fpage>2494</fpage>
        <lpage>2506</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.9b00105</pub-id>
        <?supplied-pmid 31647630?>
        <pub-id pub-id-type="pmid">31647630</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koch</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duigou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>Reinforcement learning for bioretrosynthesis</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2020</year>
        <volume>9</volume>
        <fpage>157</fpage>
        <lpage>168</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.9b00447</pub-id>
        <?supplied-pmid 31841626?>
        <pub-id pub-id-type="pmid">31841626</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Duigou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>du Lac</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>RetroRules: a database of reaction rules for engineering biology</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D1229</fpage>
        <lpage>D1235</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky940</pub-id>
        <?supplied-pmid 30321422?>
        <pub-id pub-id-type="pmid">30321422</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Algfoor</surname>
            <given-names>ZA</given-names>
          </name>
          <name>
            <surname>Sunar</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Abdullah</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kolivand</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Identification of metabolic pathways using pathfinding approaches: a systematic review</article-title>
        <source>Brief. Funct. Genomics</source>
        <year>2017</year>
        <volume>16</volume>
        <fpage>87</fpage>
        <lpage>98</lpage>
        <pub-id pub-id-type="pmid">26969656</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rahman</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Cuesta</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Furnham</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Holliday</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>EC-BLAST: a tool to automatically search and compare enzyme reactions</article-title>
        <source>Nat. Methods</source>
        <year>2014</year>
        <volume>11</volume>
        <fpage>171</fpage>
        <lpage>174</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.2803</pub-id>
        <?supplied-pmid 24412978?>
        <pub-id pub-id-type="pmid">24412978</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Selenzyme: enzyme selection tool for pathway design</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <fpage>2153</fpage>
        <lpage>2154</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty065</pub-id>
        <?supplied-pmid 29425325?>
        <pub-id pub-id-type="pmid">29425325</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hadadi</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>MohammadiPeyhani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Miskovic</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Seijo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hatzimanikatis</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Enzyme annotation for orphan and novel reactions using knowledge of substrate reactive sites</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2019</year>
        <volume>116</volume>
        <fpage>7298</fpage>
        <lpage>7307</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1818877116</pub-id>
        <?supplied-pmid 30910961?>
        <pub-id pub-id-type="pmid">30910961</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mellor</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Grigoras</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>Semisupervised gaussian process for automated enzyme search</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2016</year>
        <volume>5</volume>
        <fpage>518</fpage>
        <lpage>528</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.5b00294</pub-id>
        <?supplied-pmid 27007080?>
        <pub-id pub-id-type="pmid">27007080</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ryu</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HU</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SY</given-names>
          </name>
        </person-group>
        <article-title>Deep learning enables high-quality and high-throughput prediction of enzyme commission numbers</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2019</year>
        <volume>116</volume>
        <fpage>13996</fpage>
        <lpage>14001</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1821905116</pub-id>
        <?supplied-pmid 31221760?>
        <pub-id pub-id-type="pmid">31221760</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Parutto</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Herisson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pandit</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>XTMS: pathway design in an eXTended metabolic space</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <volume>42</volume>
        <fpage>W389</fpage>
        <lpage>W394</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gku362</pub-id>
        <?supplied-pmid 24792156?>
        <pub-id pub-id-type="pmid">24792156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <mixed-citation publication-type="other">Hafner, J. <italic>Modeling, Predicting An Mining Metabolism At Atom-level Resolution</italic> (EPFL, 2020).</mixed-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Salis</surname>
            <given-names>HM</given-names>
          </name>
        </person-group>
        <article-title>The ribosome binding site calculator</article-title>
        <source>Methods Enzymol.</source>
        <year>2011</year>
        <volume>498</volume>
        <fpage>19</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1016/B978-0-12-385120-8.00002-4</pub-id>
        <?supplied-pmid 21601672?>
        <pub-id pub-id-type="pmid">21601672</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roehner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Voigt</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Densmore</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Double dutch: a tool for designing combinatorial libraries of biological systems</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2016</year>
        <volume>5</volume>
        <fpage>507</fpage>
        <lpage>517</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.5b00232</pub-id>
        <?supplied-pmid 27110633?>
        <pub-id pub-id-type="pmid">27110633</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carbonell</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Faulon</surname>
            <given-names>J-L</given-names>
          </name>
          <name>
            <surname>Breitling</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Efficient learning in metabolic pathway designs through optimal assembling</article-title>
        <source>IFAC-PapersOnLine</source>
        <year>2019</year>
        <volume>52</volume>
        <fpage>7</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ifacol.2019.12.228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Keller, B., Miller, A., Newman, G., Vrana, J. &amp; Klavins, E. Aquarium: The Laboratory Operating System version 2.6.0. (Zenodo, 2019).</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <mixed-citation publication-type="other">The Antha Platform from Synthace. <ext-link ext-link-type="uri" xlink:href="https://synthace.com/antha-platform">https://synthace.com/antha-platform</ext-link> (2017).</mixed-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Irimia</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pau</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Rodríguez-Patón</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>BioBlocks: programming protocols in biology made easier</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>1230</fpage>
        <lpage>1232</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.6b00304</pub-id>
        <?supplied-pmid 28051850?>
        <pub-id pub-id-type="pmid">28051850</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Storch, M., Haines, M. C. &amp; Baldwin, G. S. DNA-BOT: a low-cost, automated DNA assembly platform for synthetic biology. <italic>Synth. Biol.</italic><bold>5</bold>, ysaa010 (2020).</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Röst</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Schmitt</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Aebersold</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Malmström</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>pyOpenMS: a Python-based interface to the OpenMS mass-spectrometry algorithm library</article-title>
        <source>Proteomics</source>
        <year>2014</year>
        <volume>14</volume>
        <fpage>74</fpage>
        <lpage>77</lpage>
        <pub-id pub-id-type="doi">10.1002/pmic.201300246</pub-id>
        <?supplied-pmid 24420968?>
        <pub-id pub-id-type="pmid">24420968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giacomoni</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <fpage>1493</fpage>
        <lpage>1495</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu813</pub-id>
        <?supplied-pmid 25527831?>
        <pub-id pub-id-type="pmid">25527831</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilkinson</surname>
            <given-names>MD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The FAIR Guiding Principles for scientific data management and stewardship</article-title>
        <source>Sci. Data</source>
        <year>2016</year>
        <volume>3</volume>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giardine</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Galaxy: a platform for interactive large-scale genome analysis</article-title>
        <source>Genome Res.</source>
        <year>2005</year>
        <volume>15</volume>
        <fpage>1451</fpage>
        <lpage>1455</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.4086505</pub-id>
        <?supplied-pmid 16169926?>
        <pub-id pub-id-type="pmid">16169926</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blankenberg</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dissemination of scientific software with Galaxy ToolShed</article-title>
        <source>Genome Biol.</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>403</fpage>
        <pub-id pub-id-type="doi">10.1186/gb4161</pub-id>
        <?supplied-pmid 25001293?>
        <pub-id pub-id-type="pmid">25001293</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <mixed-citation publication-type="other">Galaxy SynBioCAD portal. <ext-link ext-link-type="uri" xlink:href="https://galaxy-synbiocad.org/">https://galaxy-synbiocad.org/</ext-link> (2022).</mixed-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <mixed-citation publication-type="other">Conda — Conda documentation. <ext-link ext-link-type="uri" xlink:href="https://docs.conda.io/en/latest/">https://docs.conda.io/en/latest/</ext-link> (2022).</mixed-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Engler</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gruetzner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kandzia</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Marillonnet</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes</article-title>
        <source>PLoS ONE</source>
        <year>2009</year>
        <volume>4</volume>
        <fpage>e5553</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0005553</pub-id>
        <?supplied-pmid 19436741?>
        <pub-id pub-id-type="pmid">19436741</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gibson</surname>
            <given-names>DG</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title>
        <source>Nat. Methods</source>
        <year>2009</year>
        <volume>6</volume>
        <fpage>343</fpage>
        <lpage>345</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id>
        <?supplied-pmid 19363495?>
        <pub-id pub-id-type="pmid">19363495</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wiedmann</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ligase chain reaction (LCR)-overview and applications</article-title>
        <source>Genome Res.</source>
        <year>1994</year>
        <volume>3</volume>
        <fpage>S51</fpage>
        <lpage>S64</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.3.4.S51</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Storch</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>BASIC: a new biopart assembly standard for idempotent cloning provides accurate, single-tier DNA assembly for synthetic biology</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2015</year>
        <volume>4</volume>
        <fpage>781</fpage>
        <lpage>787</lpage>
        <pub-id pub-id-type="doi">10.1021/sb500356d</pub-id>
        <?supplied-pmid 25746445?>
        <pub-id pub-id-type="pmid">25746445</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Monk</surname>
            <given-names>JM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>iML1515, a knowledgebase that computes Escherichia coli traits</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2017</year>
        <volume>35</volume>
        <fpage>904</fpage>
        <lpage>908</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.3956</pub-id>
        <?supplied-pmid 29020004?>
        <pub-id pub-id-type="pmid">29020004</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S-W</given-names>
          </name>
          <name>
            <surname>Keasling</surname>
            <given-names>JD</given-names>
          </name>
        </person-group>
        <article-title>Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway inEscherichia coli enhances lycopene production</article-title>
        <source>Biotechnol. Bioeng.</source>
        <year>2001</year>
        <volume>72</volume>
        <fpage>408</fpage>
        <lpage>415</lpage>
        <pub-id pub-id-type="doi">10.1002/1097-0290(20000220)72:4&lt;408::AID-BIT1003&gt;3.0.CO;2-H</pub-id>
        <?supplied-pmid 11180061?>
        <pub-id pub-id-type="pmid">11180061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Production of lycopene by metabolically-engineered Escherichia coli</article-title>
        <source>Biotechnol. Lett.</source>
        <year>2014</year>
        <volume>36</volume>
        <fpage>1515</fpage>
        <lpage>1522</lpage>
        <pub-id pub-id-type="doi">10.1007/s10529-014-1543-0</pub-id>
        <?supplied-pmid 24806808?>
        <pub-id pub-id-type="pmid">24806808</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winkler</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Halweg-Edwards</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Gill</surname>
            <given-names>RT</given-names>
          </name>
        </person-group>
        <article-title>The LASER database: Formalizing design rules for metabolic engineering</article-title>
        <source>Metab. Eng. Commun.</source>
        <year>2015</year>
        <volume>2</volume>
        <fpage>30</fpage>
        <lpage>38</lpage>
        <pub-id pub-id-type="doi">10.1016/j.meteno.2015.06.003</pub-id>
        <?supplied-pmid 34150506?>
        <pub-id pub-id-type="pmid">34150506</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jessop-Fabre</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Sonnenschein</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Improving reproducibility in synthetic biology</article-title>
        <source>Front. Bioeng. Biotechnol.</source>
        <year>2019</year>
        <volume>7</volume>
        <fpage>18</fpage>
        <pub-id pub-id-type="doi">10.3389/fbioe.2019.00018</pub-id>
        <?supplied-pmid 30805337?>
        <pub-id pub-id-type="pmid">30805337</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Segler</surname>
            <given-names>MHS</given-names>
          </name>
          <name>
            <surname>Preuss</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>MP</given-names>
          </name>
        </person-group>
        <article-title>Planning chemical syntheses with deep neural networks and symbolic AI</article-title>
        <source>Nature</source>
        <year>2018</year>
        <volume>555</volume>
        <fpage>604</fpage>
        <lpage>610</lpage>
        <pub-id pub-id-type="doi">10.1038/nature25978</pub-id>
        <?supplied-pmid 29595767?>
        <pub-id pub-id-type="pmid">29595767</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <mixed-citation publication-type="other">DNA-BOT: A low-cost, automated DNA assembly platform for synthetic biology. <italic>bioRxiv</italic><ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/832139v1">https://www.biorxiv.org/content/10.1101/832139v1</ext-link> (2020).</mixed-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Borkowski</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Large scale active-learning-guided exploration for in vitro protein production optimization</article-title>
        <source>Nat. Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>1872</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-15798-5</pub-id>
        <?supplied-pmid 32312991?>
        <pub-id pub-id-type="pmid">32312991</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamp</surname>
            <given-names>Avon</given-names>
          </name>
          <name>
            <surname>Klamt</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>MEMO: a method for computing metabolic modules for cell-free production systems</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2020</year>
        <volume>9</volume>
        <fpage>556</fpage>
        <lpage>566</lpage>
        <pub-id pub-id-type="doi">10.1021/acssynbio.9b00434</pub-id>
        <?supplied-pmid 32069395?>
        <pub-id pub-id-type="pmid">32069395</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <mixed-citation publication-type="other">Soudier, P. et al. <italic>PeroxiHUB: a modular cell-free biosensing platform using H</italic><sub><italic>2</italic></sub><italic>O</italic><sub><italic>2</italic></sub><italic>as signal integrator</italic>. <italic>bioRxiv</italic><ext-link ext-link-type="uri" xlink:href="http://biorxiv.org/lookup/doi/10.1101/2022.03.16.484621">http://biorxiv.org/lookup/doi/10.1101/2022.03.16.484621</ext-link> (2022).</mixed-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <mixed-citation publication-type="other">Daylight Chemical Information Systems. <italic>SMARTS Theory Manual</italic>. (2008).</mixed-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jeske</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Placzek</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schomburg</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schomburg</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>BRENDA in 2019: a European ELIXIR core data resource</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D542</fpage>
        <lpage>D549</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1048</pub-id>
        <?supplied-pmid 30395242?>
        <pub-id pub-id-type="pmid">30395242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morgat</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Updates in Rhea – an expert curated resource of biochemical reactions</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2017</year>
        <volume>45</volume>
        <fpage>D415</fpage>
        <lpage>D418</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw990</pub-id>
        <?supplied-pmid 27789701?>
        <pub-id pub-id-type="pmid">27789701</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moretti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tran</surname>
            <given-names>VDT</given-names>
          </name>
          <name>
            <surname>Mehl</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ibberson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pagni</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>MetaNetX/MNXref: unified namespace for metabolites and biochemical reactions in the context of metabolic models</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2021</year>
        <volume>49</volume>
        <fpage>D570</fpage>
        <lpage>D574</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa992</pub-id>
        <?supplied-pmid 33156326?>
        <pub-id pub-id-type="pmid">33156326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keating</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SBML Level 3: an extensible format for the exchange and reuse of biological models</article-title>
        <source>Mol. Syst. Biol.</source>
        <year>2020</year>
        <volume>16</volume>
        <fpage>e9110</fpage>
        <pub-id pub-id-type="doi">10.15252/msb.20199110</pub-id>
        <?supplied-pmid 32845085?>
        <pub-id pub-id-type="pmid">32845085</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">Olivier, B. G. &amp; Bergmann, F. T. SBML level 3 package: flux balance constraints version 2. <italic>J. Integr. Bioinform.</italic><bold>15</bold>, 20170082 (2018).</mixed-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Novere</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Minimum information requested in the annotation of biochemical models (MIRIAM)</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2005</year>
        <volume>23</volume>
        <fpage>1509</fpage>
        <lpage>1515</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt1156</pub-id>
        <?supplied-pmid 16333295?>
        <pub-id pub-id-type="pmid">16333295</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ebrahim</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lerman</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Palsson</surname>
            <given-names>BO</given-names>
          </name>
          <name>
            <surname>Hyduke</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>COBRApy: constraints-based reconstruction and analysis for python</article-title>
        <source>BMC Syst. Biol.</source>
        <year>2013</year>
        <volume>7</volume>
        <fpage>74</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-7-74</pub-id>
        <?supplied-pmid 23927696?>
        <pub-id pub-id-type="pmid">23927696</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beber</surname>
            <given-names>ME</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>eQuilibrator 3.0: a database solution for thermodynamic constant estimation</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2022</year>
        <volume>50</volume>
        <fpage>D603</fpage>
        <lpage>D609</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab1106</pub-id>
        <?supplied-pmid 34850162?>
        <pub-id pub-id-type="pmid">34850162</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Virtanen</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title>
        <source>Nat. Methods</source>
        <year>2020</year>
        <volume>17</volume>
        <fpage>261</fpage>
        <lpage>272</lpage>
        <pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id>
        <?supplied-pmid 32015543?>
        <pub-id pub-id-type="pmid">32015543</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Naviglio</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pizzolongo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ferrara</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Aragòn</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Santini</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Extraction of pure lycopene from industrial tomato by-products in water using a new high-pressure process</article-title>
        <source>J. Sci. Food Agric.</source>
        <year>2008</year>
        <volume>88</volume>
        <fpage>2414</fpage>
        <lpage>2420</lpage>
        <pub-id pub-id-type="doi">10.1002/jsfa.3334</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <mixed-citation publication-type="other">Chen, T. &amp; Guestrin, C. XGBoost: A Scalable Tree Boosting System. in <italic>Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining</italic> 785–794 (Association for Computing Machinery, 2016). 10.1145/2939672.2939785.</mixed-citation>
    </ref>
  </ref-list>
</back>
